Search

FY Feng

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
The genomic and epigenomic landscape of double-negative metastatic prostate cancer
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Autoantibody landscape in patients with advanced prostate cancer

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.